These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 24565752)
21. Two real-time RT-PCR assays of classical swine fever virus, developed for the genetic differentiation of naturally infected from vaccinated wild boars. Liu L; Hoffmann B; Baule C; Beer M; Belák S; Widén F J Virol Methods; 2009 Jul; 159(1):131-3. PubMed ID: 19442858 [TBL] [Abstract][Full Text] [Related]
22. Efficacy of chimeric Pestivirus vaccine candidates against classical swine fever: protection and DIVA characteristics. Eblé PL; Geurts Y; Quak S; Moonen-Leusen HW; Blome S; Hofmann MA; Koenen F; Beer M; Loeffen WLA Vet Microbiol; 2013 Mar; 162(2-4):437-446. PubMed ID: 23238022 [TBL] [Abstract][Full Text] [Related]
23. Innocuousness and safety of classical swine fever marker vaccine candidate CP7_E2alf in non-target and target species. König P; Blome S; Gabriel C; Reimann I; Beer M Vaccine; 2011 Dec; 30(1):5-8. PubMed ID: 22064266 [TBL] [Abstract][Full Text] [Related]
24. Retrospective analysis of the oral immunisation of wild boar populations against classical swine fever virus (CSFV) in region Eifel of Rhineland-Palatinate. von Rüden S; Staubach C; Kaden V; Hess RG; Blicke J; Kühne S; Sonnenburg J; Fröhlich A; Teuffert J; Moennig V Vet Microbiol; 2008 Nov; 132(1-2):29-38. PubMed ID: 18534790 [TBL] [Abstract][Full Text] [Related]
25. Classical swine fever: comparison of oronasal immunisation with CP7E2alf marker and C-strain vaccines in domestic pigs. Tignon M; Kulcsár G; Haegeman A; Barna T; Fábián K; Lévai R; Van der Stede Y; Farsang A; Vrancken R; Belák K; Koenen F Vet Microbiol; 2010 Apr; 142(1-2):59-68. PubMed ID: 19857935 [TBL] [Abstract][Full Text] [Related]
26. An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus. Reimann I; Depner K; Trapp S; Beer M Virology; 2004 Apr; 322(1):143-57. PubMed ID: 15063124 [TBL] [Abstract][Full Text] [Related]
27. Comparative evaluation of live marker vaccine candidates "CP7_E2alf" and "flc11" along with C-strain "Riems" after oral vaccination. Blome S; Aebischer A; Lange E; Hofmann M; Leifer I; Loeffen W; Koenen F; Beer M Vet Microbiol; 2012 Jul; 158(1-2):42-59. PubMed ID: 22397931 [TBL] [Abstract][Full Text] [Related]
28. Does multiple oral vaccination of wild boar against classical swine fever (CSF) have a positive influence on the immunity? Kaden V; Lange E; Steyer H Dtsch Tierarztl Wochenschr; 2004 Feb; 111(2):63-7. PubMed ID: 15032263 [TBL] [Abstract][Full Text] [Related]
29. Classical swine fever virus marker vaccine strain CP7_E2alf: genetic stability in vitro and in vivo. Goller KV; Dräger C; Höper D; Beer M; Blome S Arch Virol; 2015 Dec; 160(12):3121-5. PubMed ID: 26392285 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of the oral immunisation of wild boar against classical swine fever in Baden-Württemberg. Kaden V; Renner C; Rothe A; Lange E; Hänel A; Gossger K Berl Munch Tierarztl Wochenschr; 2003; 116(9-10):362-7. PubMed ID: 14526465 [TBL] [Abstract][Full Text] [Related]
31. Differentiation of classical swine fever virus infection from CP7_E2alf marker vaccination by a multiplex microsphere immunoassay. Xia H; Harimoorthy R; Vijayaraghavan B; Blome S; Widén F; Beer M; Belák S; Liu L Clin Vaccine Immunol; 2015 Jan; 22(1):65-71. PubMed ID: 25378351 [TBL] [Abstract][Full Text] [Related]
32. DIVA vaccine properties of the live chimeric pestivirus strain CP7_E2gif. von Rosen T; Rangelova D; Nielsen J; Rasmussen TB; Uttenthal Å Vet Microbiol; 2014 Jun; 170(3-4):224-31. PubMed ID: 24629779 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of Oral Vaccine against Classical Swine Fever in Wild Boar and Estimation of the Disease Dynamics in the Quantitative Approach. Bazarragchaa E; Isoda N; Kim T; Tetsuo M; Ito S; Matsuno K; Sakoda Y Viruses; 2021 Feb; 13(2):. PubMed ID: 33672749 [TBL] [Abstract][Full Text] [Related]
34. Protection against transplacental transmission of moderately virulent classical swine fever virus using live marker vaccine "CP7_E2alf". Henke J; Carlson J; Zani L; Leidenberger S; Schwaiger T; Schlottau K; Teifke JP; Schröder C; Beer M; Blome S Vaccine; 2018 Jul; 36(29):4181-4187. PubMed ID: 29895502 [TBL] [Abstract][Full Text] [Related]
35. Oral immunisation of wild boar against classical swine fever: concluding analysis of the recent field trials in Germany. Kaden V; Heyne H; Kiupel H; Letz W; Kern B; Lemmer U; Gossger K; Rothe A; Böhme H; Tyrpe P Berl Munch Tierarztl Wochenschr; 2002; 115(5-6):179-85. PubMed ID: 12058591 [TBL] [Abstract][Full Text] [Related]
36. Epidemiological analysis of classical swine fever in wild boars in Japan. Shimizu Y; Hayama Y; Murato Y; Sawai K; Yamaguchi E; Yamamoto T BMC Vet Res; 2021 May; 17(1):188. PubMed ID: 33975588 [TBL] [Abstract][Full Text] [Related]
37. The challenges of classical swine fever control: modified live and E2 subunit vaccines. Huang YL; Deng MC; Wang FI; Huang CC; Chang CY Virus Res; 2014 Jan; 179():1-11. PubMed ID: 24211665 [TBL] [Abstract][Full Text] [Related]
38. Pre-registration efficacy study of a novel marker vaccine against classical swine fever on Maternally Derived Antibody negative (MDA-) target animals. Lévai R; Barna T; Fábián K; Blome S; Belák K; Bálint Á; Koenen F; Kulcsár G; Farsang A Biologicals; 2015 Mar; 43(2):92-9. PubMed ID: 25637578 [TBL] [Abstract][Full Text] [Related]